QHSLab, Inc.
USAQ
$0.32
-$0.03-8.57%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 24.62% | 21.24% | 26.25% | 43.54% | 50.09% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 24.62% | 21.24% | 26.25% | 43.54% | 50.09% |
| Cost of Revenue | 19.60% | 17.30% | 13.81% | 28.28% | 24.79% |
| Gross Profit | 27.16% | 23.32% | 33.35% | 52.76% | 67.31% |
| SG&A Expenses | 47.91% | 42.98% | 42.92% | 36.01% | 29.89% |
| Depreciation & Amortization | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 29.87% | 29.28% | 32.93% | 40.79% | 36.68% |
| Operating Income | -48.92% | -72.86% | -36.20% | 100.36% | 504.25% |
| Income Before Tax | 241.50% | 235.22% | 276.47% | -564.60% | -94.54% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 241.50% | 235.22% | 276.47% | -564.60% | -94.54% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 241.50% | 235.22% | 276.47% | -564.60% | -94.54% |
| EBIT | -48.92% | -72.86% | -36.20% | 100.36% | 504.25% |
| EBITDA | -33.83% | -52.02% | -26.78% | 54.19% | 630.63% |
| EPS Basic | 237.90% | 234.11% | 261.54% | -462.50% | -71.50% |
| Normalized Basic EPS | 68.08% | 39.25% | 25.97% | -460.00% | -70.40% |
| EPS Diluted | 119.02% | 104.10% | 104.14% | -337.50% | -83.86% |
| Normalized Diluted EPS | 83.19% | 61.31% | 53.29% | -337.74% | -80.80% |
| Average Basic Shares Outstanding | 21.26% | 15.46% | 9.81% | 9.93% | 11.23% |
| Average Diluted Shares Outstanding | 95.94% | 76.71% | 73.62% | 8.28% | 31.79% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |